Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Reading between the lines: direct-to-consumer advertising of genetic testing in the USA.

Hull SC, Prasad K.

Reprod Health Matters. 2001 Nov;9(18):44-8.

PMID:
11765398
2.

Direct-to-consumer marketing of genetic tests for cancer: buyer beware.

Gray S, Olopade OI.

J Clin Oncol. 2003 Sep 1;21(17):3191-3. Epub 2003 Jul 21. No abstract available.

PMID:
12874271
3.

Reading between the lines: direct-to-consumer advertising of genetic testing.

Hull SC, Prasad K.

Hastings Cent Rep. 2001 May-Jun;31(3):33-5. No abstract available.

4.

"Be ready against cancer, now": direct-to-consumer advertising for genetic testing.

William-Jones B.

New Genet Soc. 2006 Apr;25(1):89-107.

PMID:
17312631
5.
6.

Advertising genetic testing for breast cancer.

Weber LJ, Bissell MG.

Clin Leadersh Manag Rev. 2004 Jan-Feb;18(1):50-1. No abstract available.

PMID:
14968755
7.

Identifying and managing hereditary risk of breast and ovarian cancer.

Frank TS, Critchfield GC.

Clin Perinatol. 2001 Jun;28(2):395-406. Review.

PMID:
11499060
8.

Direct to confusion: lessons learned from marketing BRCA testing.

Matloff E, Caplan A.

Am J Bioeth. 2008 Jun;8(6):5-8. doi: 10.1080/15265160802248179.

PMID:
18726769
9.

Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer.

Walsh T, Casadei S, Coats KH, Swisher E, Stray SM, Higgins J, Roach KC, Mandell J, Lee MK, Ciernikova S, Foretova L, Soucek P, King MC.

JAMA. 2006 Mar 22;295(12):1379-88.

PMID:
16551709
10.
11.

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.

Berry DA, Iversen ES Jr, Gudbjartsson DF, Hiller EH, Garber JE, Peshkin BN, Lerman C, Watson P, Lynch HT, Hilsenbeck SG, Rubinstein WS, Hughes KS, Parmigiani G.

J Clin Oncol. 2002 Jun 1;20(11):2701-12.

PMID:
12039933
12.

Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.

Kauff ND, Mitra N, Robson ME, Hurley KE, Chuai S, Goldfrank D, Wadsworth E, Lee J, Cigler T, Borgen PI, Norton L, Barakat RR, Offit K.

J Natl Cancer Inst. 2005 Sep 21;97(18):1382-4.

PMID:
16174860
13.

Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.

Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, Iddenden R, Woodward ER, Lalloo F, Maher ER, Evans DG.

J Med Genet. 2007 Jan;44(1):10-15. Epub 2006 Nov 1.

14.

Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.

Fourati A, Louchez MM, Fournier J, Gamoudi A, Rahal K, El May MV, El May A, Revillion F, Peyrat JP.

Bull Cancer. 2014 Nov;101(11):E36-40. doi: 10.1684/bdc.2014.2049.

PMID:
25418591
15.

BRCA1/2 genetic testing in the community setting.

Chen WY, Garber JE, Higham S, Schneider KA, Davis KB, Deffenbaugh AM, Frank TS, Gelman RS, Li FP.

J Clin Oncol. 2002 Nov 15;20(22):4485-92.

PMID:
12431973
16.

Breast cancer risk assessment and genetic testing: complexities, conundrums, and community.

Peshkin BN.

Breast Dis. 2006-2007;27:1-3. No abstract available.

PMID:
17917137
17.

Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2.

Gabai-Kapara E, Lahad A, Kaufman B, Friedman E, Segev S, Renbaum P, Beeri R, Gal M, Grinshpun-Cohen J, Djemal K, Mandell JB, Lee MK, Beller U, Catane R, King MC, Levy-Lahad E.

Proc Natl Acad Sci U S A. 2014 Sep 30;111(39):14205-10. doi: 10.1073/pnas.1415979111. Epub 2014 Sep 5.

18.

Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.

Meijers-Heijboer H, Brekelmans CT, Menke-Pluymers M, Seynaeve C, Baalbergen A, Burger C, Crepin E, van den Ouweland AW, van Geel B, Klijn JG.

J Clin Oncol. 2003 May 1;21(9):1675-81.

PMID:
12721241
19.
20.

Breast cancer and ovarian cancer genetics.

Edlich RF, Winters KL, Lin KY.

J Long Term Eff Med Implants. 2005;15(5):533-45. Review.

PMID:
16218901

Supplemental Content

Support Center